Local Institution

Gifu, Gifu 5008727

0 studies enrolling now · 2 studies all time

What they study most

Acute Coronary Syndrome, Hepatitis C

Studies at this site

• Phase III Acute Coronary Syndrome — Stopped early
• Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy — Completed